Pen Needle Technology Optimizes Injection Technique
By HospiMedica International staff writers Posted on 04 Feb 2019 |
Image: Novel Pen needles optimize diabetic injection experience (Photo courtesy of BD).
A second-generation diabetes pen needle has been redesigned with a focus on ergonomics to provide more reliable subcutaneous injection depth.
The BD (Franklin Lakes, NJ, USA) Nano second generation Pen Needle is designed to help diabetics mitigate the risks resulting from injection force variability by implementing a contoured needle base that compensates for variable patient injection forces by first concentrating, then distributing the pressure closely around the injection site, in order to support a more reliable four mm target injection depth. The increased precision results in up to an eight-fold reduction in the calculated intramuscular injection risk.
Additional features include a 5-bevel PentaPoint comfort design, which has been clinically shown to enter the skin more easily than 3-bevel needles, providing a smoother and more comfortable injection; extra thin wall EasyFlow technology that increases insulin flow rate, making injections easier and more convenient, including for people with hand-strength challenges; and an optimal technique that aids one-handed injection for all common sites, including the arms, thighs, abdomen, and buttocks, and without requiring a skin lift.
“The launch of BD Nano 2nd generation pen needles reinforces BD's commitment to providing the most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use,” said Stanislav Glezer, MD, MBA, global vice president of medical affairs for BD. “In addition to the added clinical benefits the latest BD innovation brings, the new ergonomic pen needle features can help people feel more comfortable with their injection experience.”
Average skin thickness ranges from 1.6 - 2.4 mm within the four most common injection sites. To be absorbed properly, insulin needs to be injected into the subcutaneous tissue layer, just under the skin; but if it goes deeper, the dose may go into the muscle, which will not only cause pain but also speed up insulin absorption, potentially leading to hypoclycemia.
The BD (Franklin Lakes, NJ, USA) Nano second generation Pen Needle is designed to help diabetics mitigate the risks resulting from injection force variability by implementing a contoured needle base that compensates for variable patient injection forces by first concentrating, then distributing the pressure closely around the injection site, in order to support a more reliable four mm target injection depth. The increased precision results in up to an eight-fold reduction in the calculated intramuscular injection risk.
Additional features include a 5-bevel PentaPoint comfort design, which has been clinically shown to enter the skin more easily than 3-bevel needles, providing a smoother and more comfortable injection; extra thin wall EasyFlow technology that increases insulin flow rate, making injections easier and more convenient, including for people with hand-strength challenges; and an optimal technique that aids one-handed injection for all common sites, including the arms, thighs, abdomen, and buttocks, and without requiring a skin lift.
“The launch of BD Nano 2nd generation pen needles reinforces BD's commitment to providing the most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use,” said Stanislav Glezer, MD, MBA, global vice president of medical affairs for BD. “In addition to the added clinical benefits the latest BD innovation brings, the new ergonomic pen needle features can help people feel more comfortable with their injection experience.”
Average skin thickness ranges from 1.6 - 2.4 mm within the four most common injection sites. To be absorbed properly, insulin needs to be injected into the subcutaneous tissue layer, just under the skin; but if it goes deeper, the dose may go into the muscle, which will not only cause pain but also speed up insulin absorption, potentially leading to hypoclycemia.
Latest Critical Care News
- AI to Improved Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia